InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| pWHERE | Activation of NPFFR2 leads to hyperalgesia through the spinal inflammatory me... | 2017 | Exp Neurol. | Lin Y.T. et al. | DOI: 10.1016/j.expneurol.2017.02.003 |
| Poly(I:C) (HMW) Rhodamine | DNA inhibits dsRNA-induced secretion of pro-inflammatory cytokines by gingiva... | 2012 | Immunobiology | Cherepanova A.V. et al. | DOI: 10.1016/j.imbio.2012.05.017 |
| HEK-Blue™ Null1 Cells | Engagement of Platelet Toll-Like Receptor 9 by Novel Endogenous Ligands Promo... | 2013 | Circ Res. | Panigrahi S. et al.. | DOI: 10.1161/CIRCRESAHA.112.274241 |
| ODN 1826 VacciGrade™ | Rational design of nanoparticles towards targeting antigen-presenting cells a... | 2017 | J Control Release. | Zupančič E. et al. | DOI: 10.1016/j.jconrel.2017.05.014 |
| pVITRO1-MCS | Enhancement of immune response to a DNA vaccine against Mycobacterium tubercu... | 2013 | Vaccine. | Meerak J. et al. | DOI: 10.1016/j.vaccine.2012.11.075 |
| Zymosan | Reduced PICD in Monocytes Mounts Altered Neonate Immune Response to Candida a... | 2016 | PLoS One. | Dreschers S. et al. | DOI: 10.1371/journal.pone.0166648 |
| Human TLR4 Reporter HEK293 Cells (NF-κB) | Steady-state antigen scavenging, cross-presentation, and CD8+ T cell priming:... | 2014 | J Immunol. | Hirosue S. et al. | DOI: 10.4049/jimmunol.1302492 |
| Normocin® - Antimicrobial Reagent | Inhibition of telomerase RNA decay rescues telomerase deficiency caused by dy... | 2016 | Nat Struct Mol Biol. | Shukla S. et al. | DOI: 10.1038/nsmb.3184 |
| ODN 2006 (ODN 7909) | Activation of human B cells negatively regulates TGF-β1 production. | 2017 | J Neuroinflammation. | Molnarfi N. et al. | DOI: 10.1186/s12974-017-0798-5 |
| DNA synthesis inhibitor | An optimized triple modality reporter for quantitative in vivo tumor imaging ... | 2014 | PLoS One. | Levin R.A. et al. | DOI: 10.1371/journal.pone.0097415 |
| PRR Compound Screening and Profiling Service | Drugs Implicated in Systemic Autoimmunity Modulate Neutrophil Extracellular T... | 2018 | Arthritis Rheumatol. | Irizarry-Caro J.A. et al. | DOI: 10.1002/art.40372 |
| Human TLR2 Reporter HEK293 Cells (NF-κB) | Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a pr... | 2015 | Sci Signal. | Daniele S.G. et al. | DOI: 10.1126/scisignal.2005965 |
| R848 (Resiquimod) | TLR4 signals in B lymphocytes are transduced via the B cell antigen receptor ... | 2017 | J Exp Med. | Schweighoffer E. et al. | DOI: 10.1084/jem.20161117 |
| R848 VacciGrade™ | K+ Efflux-Independent NLRP3 Inflammasome Activation by Small Molecules Target... | 2016 | Immunity. | Groß C.J. et al. | DOI: 10.1016/j.immuni.2016.08.010 |
| ATP | Targeting IL-17A attenuates neonatal sepsis mortality induced by IL-18. | 2016 | PNAS | Wynn JL. et al. | DOI: 10.1073/pnas.1515793113 |
| ODN M362 - TLR9 ligand | CCL19-CCR7-dependent reverse transendothelial migration of myeloid cells clea... | 2016 | Nat Immunol. | Roufaiel M. et al. | DOI: 10.1038/ni.3564 |
| Peptide M / Agarose | Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope b... | 2013 | PNAS | Tomaras G.D. et al. | DOI: 10.1073/pnas.1301456110 |
| Caspase-1 and Caspase-4 inhibitor | Role of IRF1 in governing Treg depletion, Th1 polarization, inflammasome acti... | 2017 | Int J Cancer. | Buccione C. et al. | DOI: 10.1002/ijc.31083 |
| Poly(I:C) HMW | PolyI:C and CpG Synergize with Anti-ErbB2 mAb for Treatment of Breast Tumors ... | 2017 | Cancer Res. | Charlebois R. et al. | DOI: 10.1158/0008-5472.CAN-16-1873 |
| 5'ppp-dsRNA | Tissue-Resident Macrophages Are Locally Programmed for Silent Clearance of Ap... | 2017 | Immunity. | Roberts A.W. et al. | DOI: 10.1016/j.immuni.2017.10.006 |